Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Liver organoids: Current advances and future applications for hepatology

Yohan Kim, Minseok Kang, Michael Girma Mamo, Michael Adisasmita, Meritxell Huch, Dongho Choi

Clin Mol Hepatol. 2025;31(Suppl):S327-S348. Published online December 26, 2024

DOI: https://doi.org/10.3350/cmh.2024.1040

View: 1837 Download: 252

Original Article

Outcomes after liver transplantation in Korea: Incidence and risk factors from Korean transplantation registry

Jong Man Kim, Deok Gie Kim, Jihyun Kim, Keunsung Lee, Kwang-Woong Lee, Je Ho Ryu, Bong-Wan Kim, Dong Lak Choi, Young Kyoung You, Dong-Sik Kim, Yang Won Nah, Koo Jeong Kang, Jai Young Cho, Geun Hong, Hee Chul Yu, Ju Ik Moon, Dongho Choi, Shin Hwang, Myoung Soo Kim

Clin Mol Hepatol. 2021;27(3):451-462. Published online February 2, 2021

DOI: https://doi.org/10.3350/cmh.2020.0292

View: 8754 Download: 328 Web of Science: 40 Crossref: 43

Review

Clinical implications of advances in liver regeneration

Yong Jin Kwon, Kyeong Geun Lee, Dongho Choi

Clin Mol Hepatol. 2015;21(1):7-13. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.7

View: 12542 Download: 224 Web of Science: 50 Crossref: 45

1 |

Viewed By 8717	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7547	MAFLD: How is it different from NAFLD?
Viewed By 5446	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 5047	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4575	Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease

Cited By 322	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 292	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 203	MAFLD: How is it different from NAFLD?
Cited By 101	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 92	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search